Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
04
Providing nuclear medicine solutions for blood disorders and related cancers.
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
08
Enhancing the detection and monitoring of bone and joint conditions.
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
10
Advancing brain imaging solutions for neurological disorders and diseases.
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.

Selected

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

Dopacis®

Fluorodopa (18F) 90 MBq/mL solution for injection

Active ingredient

F18-fluorodopa

Disease area

Neurology, Oncology

Available in
, 

Dopacis® in Belgium

Product information
, 

Dopacis® in France

Product information
, 

Dopacis® in International

Product information
, 

Dopacis® in Italy

Product information
, 

Dopacis® in Luxembourg

Product information
, 

Dopacis® in Malta

Product information
, 

Dopacis® in Netherlands

Product information
, 

Dopacis® in Portugal

Product information
, 

Dopacis® in Slovenia

Product information

Dopacis® in Spain

Product information

ERtracER

ERtracER Solution for Injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

ERtracER in International

Product information
, 

ERtracER in Ireland

Product information

ERtracER in United Kingdom

Product information

Fludeomap

Fludeomap 250 MBq/ml solution for injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeomap in Estonia

Product information
, 

Fludeomap in Finland

Product information
, 

Fludeomap in Latvia

Product information
, 

Fludeomap in Lithuania

Product information
, 

Fludeomap in Norway

Product information

Fludeomap in Sweden

Product information

Fludeoxyglucose (18F)-Curium

Fludeoxyglucose (18F)-Curium 185 MBq/mL solution for injection

Active ingredient

F18-fludesoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeoxyglucose (18F)-Curium in Austria

Product information
, 

Fludeoxyglucose (18F)-Curium in Belgium

Product information
, 

Fludeoxyglucose (18F)-Curium in France

Product information
, 

Fludeoxyglucose (18F)-Curium in International

Product information
, 

Fludeoxyglucose (18F)-Curium in Italy

Product information
, 

Fludeoxyglucose (18F)-Curium in Luxembourg

Product information
, 

Fludeoxyglucose (18F)-Curium in Malta

Product information
, 

Fludeoxyglucose (18F)-Curium in Netherlands

Product information
, 

Fludeoxyglucose (18F)-Curium in Portugal

Product information
, 

Fludeoxyglucose (18F)-Curium in Slovenia

Product information

Fludeoxyglucose (18F)-Curium in Spain

Product information

Fludeoxyglucose (18F)

Fludeoxyglucose (18F) Monrol 200-2200 MBq/ml solution for injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeoxyglucose (18F) in Bulgaria

Product information
, 

Fludeoxyglucose (18F) in Greece

Product information

Fludeoxyglucose (18F) in Romania

Product information

GlucoTep

GlucoTep 150 MBq/mL solution for injection

Active ingredient

F18-fludesoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in

GlucoTep in France

Product information

Indium (111In) DTPA

Indium (111In) DTPA 37 MBq/mL solution for injection

Active ingredient

In111-pentetate

Disease area

Neurology

Available in
, 

Indium (111In) DTPA in Belgium

Product information
, 

Indium (111In) DTPA in Czech Republic

Product information
, 

Indium (111In) DTPA in Denmark

Product information
, 

Indium (111In) DTPA in Finland

Product information
, 

Indium (111In) DTPA in France

Product information
, 

Indium (111In) DTPA in Germany

Product information
, 

Indium (111In) DTPA in Greece

Product information
, 

Indium (111In) DTPA in Ireland

Product information
, 

Indium (111In) DTPA in Italy

Product information
, 

Indium (111In) DTPA in Netherlands

Product information
, 

Indium (111In) DTPA in Spain

Product information

Indium (111In) DTPA in United Kingdom

Product information

Ioflupane I 123 Injection

Ioflupane I 123 Injection

Active ingredient

Ioflupane I 123

Disease area

Neurology

Available in

Ioflupane I 123 Injection in United States

Product information

Kit for the Preparation of Technetium Tc 99m Pentetate Injection

(commonly known as DTPA)

Active ingredient

diethylenetriaminepentaacetic acid

Disease area

Nephrology, Neurology, Pulmonology

Available in

Kit for the Preparation of Technetium Tc 99m Pentetate Injection in United States

Product information

Striascan™

Striascan 74 MBq/mL solution for injection

Active ingredient

I123-ioflupane

Disease area

Neurology

Available in
, 

Striascan™ in Austria

Product information
, 

Striascan™ in Belgium

Product information
, 

Striascan™ in Bulgaria

Product information
, 

Striascan™ in Croatia

Product information
, 

Striascan™ in Cyprus

Product information
, 

Striascan™ in Czech Republic

Product information
, 

Striascan™ in Denmark

Product information
, 

Striascan™ in Estonia

Product information
, 

Striascan™ in Finland

Product information
, 

Striascan™ in France

Product information
, 

Striascan™ in Germany

Product information
, 

Striascan™ in Greece

Product information
, 

Striascan™ in Hungary

Product information
, 

Striascan™ in Iceland

Product information
, 

Striascan™ in International

Product information
, 

Striascan™ in Ireland

Product information
, 

Striascan™ in Italy

Product information
, 

Striascan™ in Latvia

Product information
, 

Striascan™ in Lithuania

Product information
, 

Striascan™ in Luxembourg

Product information
, 

Striascan™ in Malta

Product information
, 

Striascan™ in Netherlands

Product information
, 

Striascan™ in Norway

Product information
, 

Striascan™ in Poland

Product information
, 

Striascan™ in Portugal

Product information
, 

Striascan™ in Romania

Product information
, 

Striascan™ in Slovakia

Product information
, 

Striascan™ in Slovenia

Product information
, 

Striascan™ in Spain

Product information
, 

Striascan™ in Sweden

Product information
, 

Striascan™ in Switzerland

Product information
, 

Striascan™ in Turkey

Product information

Striascan™ in United Kingdom

Product information

Technescan™ DTPA

TechneScan DTPA 20.8 mg kit for radiopharmaceutical preparation

Active ingredient

Pentetic acid

Disease area

Nephrology, Neurology, Pulmonology, Urology

Available in
, 

Technescan™ DTPA in Austria

Product information
, 

Technescan™ DTPA in Belgium

Product information
, 

Technescan™ DTPA in Colombia

Product information
, 

Technescan™ DTPA in Czech Republic

Product information
, 

Technescan™ DTPA in Denmark

Product information
, 

Technescan™ DTPA in Finland

Product information
, 

Technescan™ DTPA in France

Product information
, 

Technescan™ DTPA in Germany

Product information
, 

Technescan™ DTPA in Greece

Product information
, 

Technescan™ DTPA in Hong Kong

Product information
, 

Technescan™ DTPA in Hungary

Product information
, 

Technescan™ DTPA in Ireland

Product information
, 

Technescan™ DTPA in Italy

Product information
, 

Technescan™ DTPA in Mexico

Product information
, 

Technescan™ DTPA in Moldova

Product information
, 

Technescan™ DTPA in Netherlands

Product information
, 

Technescan™ DTPA in Norway

Product information
, 

Technescan™ DTPA in Peru

Product information
, 

Technescan™ DTPA in Portugal

Product information
, 

Technescan™ DTPA in Republic of Korea

Product information
, 

Technescan™ DTPA in Romania

Product information
, 

Technescan™ DTPA in Singapore

Product information
, 

Technescan™ DTPA in Slovakia

Product information
, 

Technescan™ DTPA in Spain

Product information
, 

Technescan™ DTPA in Sweden

Product information
, 

Technescan™ DTPA in Switzerland

Product information
, 

Technescan™ DTPA in Turkey

Product information

Technescan™ DTPA in United Kingdom

Product information

Xenon Xe 133 Gas

Xenon Xe 133 Gas

Active ingredient

Xenon Xe-133

Disease area

Neurology, Pulmonology

Available in

Xenon Xe 133 Gas in United States

Product information

Xenotron™ I Dispenser

Xenon (Xe 133) Gas Dispenser

Active ingredient

N/A device

Disease area

Neurology, Pulmonology

Available in

Xenotron™ I Dispenser in United States

Product information